Treatment and research Web Team 20/08/2026 Treatment and research Web Team 20/08/2026

Personalised cancer vaccine succeeds in Phase 3: what could it mean for lung cancer?

Read More

Prevention and risk Web Team 16/08/2026 Prevention and risk Web Team 16/08/2026

Hotter Summers, Dirtier Air: Heatwaves and Lung Cancer in Europe

Read More

Policy and EU affairs, Living with lung cancer Web Team 12/08/2026 Policy and EU affairs, Living with lung cancer Web Team 12/08/2026

Who counts as a lung cancer expert?

Read More

Biomarkers and diagnosis Web Team 07/08/2026 Biomarkers and diagnosis Web Team 07/08/2026

Lung cancer staging: is TNM still enough?

Read More

Lung Cancer Europe and members Web Team 06/08/2026 Lung Cancer Europe and members Web Team 06/08/2026

Small cell lung cancer webinar: help us spread the word

Read More

Biomarkers and diagnosis, Access to treatment Web Team 05/08/2026 Biomarkers and diagnosis, Access to treatment Web Team 05/08/2026

Biomarker testing is moving faster than ever. Is Europe keeping up?

Read More

Policy and EU affairs Web Team 02/08/2026 Policy and EU affairs Web Team 02/08/2026

Backing the call for a European Lung Health Plan

Read More

Living with lung cancer Web Team 01/08/2026 Living with lung cancer Web Team 01/08/2026

World Lung Cancer Day: The Years We Don’t Count

Read More

Lung Cancer Europe and members, Screening and early diagnosis Web Team 01/08/2026 Lung Cancer Europe and members, Screening and early diagnosis Web Team 01/08/2026

Get Checked 2026

Read More

Prevention and risk Web Team 28/07/2026 Prevention and risk Web Team 28/07/2026

Wildfire smoke and lung cancer: what does the evidence show?

Read More

Access to treatment, Treatment and research Web Team 25/07/2026 Access to treatment, Treatment and research Web Team 25/07/2026

A new ROS1 lung cancer drug has reached patients in the US. What happens next in Europe?

The US has approved zidesamtinib for ROS1-positive lung cancer, but it is not yet submitted for approval in Europe. What this means for access.

Read More

Policy and EU affairs Web Team 25/07/2026 Policy and EU affairs Web Team 25/07/2026

Lung Cancer Europe’s position on artificial intelligence in lung cancer care

Read More

Living with lung cancer Web Team 24/07/2026 Living with lung cancer Web Team 24/07/2026

Why People with Lung Cancer Face a Higher Risk of Hospital Infections

Read More

Policy and EU affairs Web Team 20/07/2026 Policy and EU affairs Web Team 20/07/2026

Europe's next long term budget: new briefing highlights key issues for lung cancer

Read More

Treatment and research Web Team 19/07/2026 Treatment and research Web Team 19/07/2026

BMI, the Gut Microbiome and Immunotherapy: New Nature Study Explores the Obesity Paradox

Read More

Treatment and research, Biomarkers and diagnosis Web Team 17/07/2026 Treatment and research, Biomarkers and diagnosis Web Team 17/07/2026

TROP2 and lung cancer: what we know so far

Read More

Lung Cancer Europe and members Web Team 15/07/2026 Lung Cancer Europe and members Web Team 15/07/2026

New reports capture the Lung Cancer Europe 2026 Conference

Read More

Screening and early diagnosis Web Team 14/07/2026 Screening and early diagnosis Web Team 14/07/2026

How Doctors Find and Remove Tiny Lung Nodules

Read More

Treatment and research Web Team 10/07/2026 Treatment and research Web Team 10/07/2026

New Treatments for Small Cell Lung Cancer in Europe

Read More

Policy and EU affairs, Prevention and risk Web Team 08/07/2026 Policy and EU affairs, Prevention and risk Web Team 08/07/2026

9 takeaways for the lung cancer community from the WHO's new cancer report

Read More